Document Detail


Current understanding of TRPM7 pharmacology and drug development for stroke.
MedLine Citation:
PMID:  22820907     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The initial excitement and countles efforts to find a pharmacological agent that disrupts the excitotoxic pathway of ischemic neuronal death have only led to disappointing clinical trials. Currently, a thrombolytic agent called recombinant tissue plasminogen activator (rt-PA) is the only pharmacological treatment available for patients with acute ischemic stroke in most countries. Even though its efficacy has been confirmed repeatedly, rt-PA is considerably underused due to reasons including a short therapeutic window and repeated complications associated with its use. A search for alternative mechanisms that may operate dependently or independently with the well-established excitotoxic mechanism has led researchers to the discovery of newly described non-glutamate mechanisms. Among the latter, transient receptor potential melastatin 7 (TRPM7) is one of the important nonglutamate mechanisms in stroke, which has been evaluated in both in-vitro and in-vivo. In this review, we will discuss the current state of pharmacological treatments of ischemic stroke and provide evidence that TRPM7 is a promising therapeutic target of stroke.
Authors:
Christine You Jin Bae; Hong-Shuo Sun
Related Documents :
23669047 - Conflation of cocaine seeking and cocaine taking responses in iv self-administration ex...
21445277 - Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylat...
21208167 - Brain injury associated with widely abused amphetamines: neuroinflammation, neurogenesi...
23346447 - Cocaine induced vasculitis: have we found a culprit?
22676567 - Illegal drugs, anti-drug policy failure, and the need for institutional reforms in colo...
10842027 - Segmental analysis for cocaine and metabolites by hplc in hair of suspected drug overdo...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-23
Journal Detail:
Title:  Acta pharmacologica Sinica     Volume:  -     ISSN:  1745-7254     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100956087     Medline TA:  Acta Pharmacol Sin     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Departments of Surgery, Physiology, and Pharmacology, Institute of Medical Science, Faculty of Medicine, University of Toronto, 1 King's College Circle, Toronto, Ontario, Canada, M5S 1A8.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Surface-enhanced Raman scattering (SERS) revealing chemical variation during biofilm formation: from...
Next Document:  Pharmacokinetic interactions between ilaprazole and clarithromycin following ilaprazole, clarithromy...